Labatec Pharma announces an exclusive licensing agreement signed with AFT Pharmaceuticals, to commercialise MAXIGESIC IV®, in Switzerland
29 March 2023
31 to 01
September
2023
Interlaken
22 to 23
September
2023
Lausanne Switzerland
2 to 4
November
2023
Beaulieu, Lausanne
29 to 1
December
2023
Geneva
7 to 8
June
2023
New York, USA
25 to 26
September
2023
Vienna, Austria
24 to 26
October
2023
Barcelona, Spain
6 to 8
November
2023
Munich, Germany
Would you like to discuss a collaboration or partnership project? Get in touch with us at partnering@labatec.com or connect with us at one of the upcoming events.
For other enquiries, please visit our contact page.